1,721,029 research outputs found
Price indexes for clinical trial research: a feasibility study
Research support from the National Science Foundation, Collaborative Research: “An Experimental Producer Price Index for Clinical Trials” to the National Bureau of Economic Research, Award Number 0915674, and Boston University, Award Number 0915677, is gratefully acknowledged. We thank Medidata Solutions Worldwide, Inc. (“Medidata”) for supplying database extracts, Ed Seguine (formerly at Fast Track Solutions, Inc. and Medidata) for helpful discussions, Rafael Campo and other individuals
at Medidata for helpful comments and data support, and Marshall Reinsdorf from the Bureau of Economic Analysis for constructive discussant’s comments at the Annual Meetings of the American Economic Association in San Diego, CA, January 6, 2013. Rania Gihleb provided able research assistance.
The opinions expressed herein are those of the authors, and do not necessarily reflect those of the National
Science Foundation, Medidata, or the institutions with whom the authors are affiliated. The views
expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau
of Economic Researc
Scale, scope and spillovers : the determinants of research productivity in ethical drug discovery
Includes bibliographical references (p. 25-27).Funded by four pharmaceutical companies and by the Sloan Foundation.Rebecca Henderson & Iain Cockburn
Racing or spilling? : the determinants of research productivity in ethical drug discovery
Includes bibliographical references (p. 13-14).Research funded by four pharmaceutical companies and by the Sloan Foundation.Rebecca Henderson and Iain Cockburn
Going Beyond Counting First Authors in Author Co-citation Analysis
The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Racing to invest? : the dynamics of competition in ethical drug discovery
Includes bibliographical references (p. 21-23).Funded by the Sloan Foundation and by four pharmaceutical companies.Iain Cockburn, Rebecca Henderson
Measuring competence? : exploring firm effects in pharmaceutical research
Includes bibliographical references (p. 24-27).Supported by four pharmaceutical companies and the Sloan Foundation.Rebecca Henderson, Iain Cockburn
Appropriate Similarity Measures for Author Cocitation Analysis
We provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Dispelling the Myths Behind First-author Citation Counts
We conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
- …
